All mice transplanted with the MLL-ENL-transduced cells developed AML within 75 days; while none of the parental mice developed disease up to 100 days after injection (Fig. 1f), confirmed by the absence of GFP+ cells in the peripheral blood, spleen and bone marrow (Supplementary Fig. 1c). This evidence concerns the gene KMT2A and acute myeloid leukemia.